Zobrazeno 1 - 10
of 219
pro vyhledávání: '"R. Küfer"'
Publikováno v:
Der Urologe. Ausg. A. 57(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab11680d355851b1d410a7a4d3aebb8f
https://pubmed.ncbi.nlm.nih.gov/23064867
https://pubmed.ncbi.nlm.nih.gov/23064867
Publikováno v:
Der Urologe. 52:226-239
Ziel dieser Studie war es zu evaluieren, wie in Deutschland praktizierende Facharzte fur Urologie der DGU Prostatastanzbiopsien (Bx) durchfuhren und wie pathohistologische Befundberichte von Ihnen genutzt werden, um Behandlungsentscheidungen zu treff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb1de8391584a5c59987671129b1cb92
https://doi.org/10.1007/s00120-012-3008-1
https://doi.org/10.1007/s00120-012-3008-1
Publikováno v:
Der Urologe. 48:1295-1301
Androgen withdrawal or surgical castration remains the standard therapy for advanced prostate cancer disease. Even for castration-resistant prostate cancer the therapeutic option of docetaxel-based chemotherapy is well studied and defined. Facing dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e46fb452deb86c274daafb30d5134216
https://doi.org/10.1007/s00120-009-2111-4
https://doi.org/10.1007/s00120-009-2111-4
Publikováno v:
Der Urologe. 48:1302-1307
In cancer therapy vastly different kinds of treatment regimens, but as a rule scientifically validated and reviewed, play a central role dependent on the tumor entity. Besides the options of schoolbook medicine complementary, alternative and supporti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f349d43f6f96b0a89004821164051f3f
https://doi.org/10.1007/s00120-009-2110-5
https://doi.org/10.1007/s00120-009-2110-5
Publikováno v:
Der Urologe. 48:1308-1317
In the last 5 years the paradigms for the treatment of metastatic renal cell cancer have fundamentally changed. Until 2005 systemic therapy was limited to the immunomodulating cytokines interferon-alfa and interleukin-2, in recent years, however, tyr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b49bb8fac50144c25ea41e51788c4f78
https://doi.org/10.1007/s00120-009-2109-y
https://doi.org/10.1007/s00120-009-2109-y
Publikováno v:
Der Urologe. 48:516-522
Hypogonadism is highly prevalent in the elderly and in men with prostate cancer. Symptoms of hypogonadism, such as depression, lack of libido, and decreased bone mineral density, can significantly impair quality of life. In addition, testosterone pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88f3c5383f10d18c49df31a19324b099
https://doi.org/10.1007/s00120-009-1954-z
https://doi.org/10.1007/s00120-009-1954-z
Autor:
R. Küfer, Alexander Kluge, Wolfgang Luboldt, T. L. Toussaint, N. M. Blumstein, M. D. Seemann, Hans-Joachim Luboldt
Publikováno v:
Radiology. 249:1017-1025
In a technical development study approved by the institutional ethics committee, the feasibility of fast diffusion-weighted imaging as a replacement for conventional magnetic resonance (MR) imaging sequences (short inversion time inversion recovery [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00f3d0c0168e292622b57b501e4272cb
https://doi.org/10.1148/radiol.2492080038
https://doi.org/10.1148/radiol.2492080038
Publikováno v:
Der Urologe. 47:1334-1338
Almost all patients with hormone-refractory prostate cancer under primary androgen deprivation therapy will develop progression, frequently initially marked by an asymptomatic increase of prostate-specific antigen (PSA). Recent data showed that taxan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9778dcb5c634d685ee9e8a0daf472945
https://doi.org/10.1007/s00120-008-1781-7
https://doi.org/10.1007/s00120-008-1781-7
Publikováno v:
Der Urologe. 47:596-600
Die Nomenklatur der Blasenfunktionsstorungen erfolgt nach Abstimmung der deutschen Fachgesellschaften nach der AWMF-Empfehlung von 2004. Es existiert keine Uberleitung dieser Nomenklatur auf die Diagnosen, die in der Klassifikation des ICD-10-GM-Kata
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07de1da1500e3e11f01875b2754b172c
https://doi.org/10.1007/s00120-008-1672-y
https://doi.org/10.1007/s00120-008-1672-y
Autor:
K.D. Spindler, S.V. Schütz, Richard E. Hautmann, E. Schmid, Ludwig Rinnab, Marcus V. Cronauer, A. Hessenauer, R. Küfer, F. Finter
Publikováno v:
Der Urologe. 47:314-325
Die Entstehung hormonrefraktarer Prostatakarzinomzellen wahrend einer Hormonablationstherapie stellt die Hauptursache fur den Tumorprogress und die hohe Mortalitatsrate des fortgeschrittenen Prostatakarzinoms (PCA) dar. Wahrend in vitro der Verlust d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::526231ca61042b06dfdb8b75aabc83d7
https://doi.org/10.1007/s00120-008-1637-1
https://doi.org/10.1007/s00120-008-1637-1